Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Increases By 72.3%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 5,312 shares, an increase of 72.3% from the August 15th total of 3,083 shares. Based on an average daily volume of 64,523 shares, the days-to-cover ratio is presently 0.1 days.

Alpha Tau Medical Price Performance

DRTSW traded up $0.12 on Wednesday, hitting $4.16. The company had a trading volume of 123,479 shares, compared to its average volume of 62,088. The stock has a fifty day moving average price of $3.58 and a 200-day moving average price of $2.31. Alpha Tau Medical has a 12-month low of $0.20 and a 12-month high of $4.29.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.